{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:50:30Z","timestamp":1793260230094,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473274"],"award-info":[{"award-number":["81473274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773806"],"award-info":[{"award-number":["81773806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874331"],"award-info":[{"award-number":["81874331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022PEAC03"],"award-info":[{"award-number":["2022PEAC03"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00574","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:43:18Z","timestamp":1742604198000},"page":"e00574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The optimal timing for initiating oral anticoagulant in ischemic stroke combined with non-valvular atrial fibrillation patients: A real-world big data analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Wenxuan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0617-5840","authenticated-orcid":false,"given":"Jun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neurot.2025.e00574_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105893","article-title":"Anticoagulation protocol for secondary prevention of acute ischemic stroke associated with nonvalvular atrial fibrillation","volume":"30","author":"Kimura","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00574_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18816","article-title":"Assessment of trends in guideline-based oral anticoagulant prescription for patients with ischemic stroke and atrial fibrillation in China","volume":"4","author":"Gu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00574_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ehjcvp\/pvz035","article-title":"Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs","volume":"6","author":"Wang","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00574_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (timing): a registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00574_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.42964","article-title":"Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010-2020","volume":"5","author":"Ko","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00574_bib6","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"European heart Rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00574_bib7","first-page":"760","article-title":"Expert consensus on cardiogenic stroke treatment in China (2022)","volume":"102","author":"Liu","year":"2022","journal-title":"Chinese Medical Association"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00574_bib8","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","article-title":"Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events","volume":"87","author":"Seiffge","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00574_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","article-title":"Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study","volume":"90","author":"Wilson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00574_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/jnnp-2021-327236","article-title":"Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis","volume":"93","author":"De Marchis","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl A100","key":"10.1016\/j.neurot.2025.e00574_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ijs.12569","article-title":"The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods","volume":"10","author":"Charidimou","year":"2015","journal-title":"Int J Stroke"},{"issue":"26","key":"10.1016\/j.neurot.2025.e00574_bib12","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00574_bib13","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00574_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study","volume":"6","author":"Paciaroni","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00574_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1055\/a-1669-4987","article-title":"Oral anticoagulation timing in patients with acute ischemic stroke and atrial fibrillation","volume":"122","author":"Chang","year":"2021","journal-title":"Thromb Haemost"},{"issue":"10464","key":"10.1016\/j.neurot.2025.e00574_bib16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(24)02197-4","article-title":"Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial","volume":"404","author":"Werring","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00574_bib17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00574_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/BSD.0000000000000932","article-title":"Propensity score matching: a statistical method","volume":"33","author":"Kane","year":"2020","journal-title":"Clin Spine Surg"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00574_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.arthro.2021.06.037","article-title":"Best practice guidelines for propensity score methods in medical research: consideration on theory, implementation, and reporting. A review","volume":"38","author":"Chen","year":"2022","journal-title":"Arthroscopy"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00574_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.36469\/9774","article-title":"Cost-benefit analysis of VKA versus NOAC treatment in German patients with atrial fibrillation utilizing patient self-testing","volume":"6","author":"Diel","year":"2019","journal-title":"J Health Econ Outcomes Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00574_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266658","article-title":"Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain","volume":"17","author":"Escobar Cervantes","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00574_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5334\/gh.774","article-title":"NOACs added to WHO's essential medicines list: recommendations for future policy actions","volume":"15","author":"Di Cesare","year":"2020","journal-title":"Glob Heart"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00574_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.STR.14.5.688","article-title":"Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study","volume":"14","author":"Hart","year":"1983","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00574_bib24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/STROKEAHA.121.036695","article-title":"Practical \"1-2-3-4-Day\" rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study","volume":"53","author":"Kimura","year":"2022","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00574_bib25","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s10072-023-06717-9","article-title":"Application of the \"1-2-3-4-day\" rule to stroke severity at baseline versus at 24 h to start direct oral anticoagulant for atrial fibrillation within 7 days from symptom onset","volume":"44","author":"Cappellari","year":"2023","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00574_bib26","first-page":"789","article-title":"Stroke prevention in atrial fibrillation: an Asian perspective","volume":"111","author":"Chiang","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.neurot.2025.e00574_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2020.04.070","article-title":"Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter","volume":"317","author":"Shah","year":"2020","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00574_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2022.04.094","article-title":"P73 real-world effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOAC) in patients with non-valvular atrial fibrillation (NVAF): a retrospective cohort study in Singapore","volume":"25","author":"Foo","year":"2022","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00574_bib29","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1007\/s00415-024-12204-8","article-title":"Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA study","volume":"271","author":"Rigual","year":"2024","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00574_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","article-title":"Retrospective studies - utility and caveats","volume":"50","author":"Talari","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00574_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1200\/OP.23.00519","article-title":"Significance of confounding factors in retrospective observational studies","volume":"20","author":"Ergun","year":"2024","journal-title":"JCO Oncol Pract"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:46:10Z","timestamp":1778831170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925000522"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00574","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The optimal timing for initiating oral anticoagulant in ischemic stroke combined with non-valvular atrial fibrillation patients: A real-world big data analysis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00574"}}